|
Neonatal Intensive Care Drug Manual
|
| bet | 107/654 | | Sana | 03.01.2022 | | Hajmi | 1,5 Mb. | | #14803 |
Chloral Hydrate
Revision Date : 27/04/2021
|
Approved : TC,KOH
|
Alert
|
High alert medication: risk of causing significant patient harm when used in error.
Chloral hydrate should not be given by non-medical personnel in non-medical environment.
Osmolality is 3285 mOsm/kg of water
|
Indication
|
Sedation for painless procedure (e.g. neuroimaging).
Sedative/hypnotic for short-term use.
|
Action
|
Exact mechanism of sedation is not yet known. Trichloroethanol (TCE) is considered to produce the sedative effect associated with this drug.
|
Drug Type
|
Sedative and hypnotic drug with barbiturate-like features.
|
Trade Name
|
Chloral Hydrate Mixture 1 g/10 mL, (100 mg/mL) manufacturer: Perrigo Australia
|
Presentation
|
Chloral Hydrate Mixture 1 g/10 mL (100 mg/mL) oral liquid, 200 mL
|
|
|
| |
